Clinical Significance of Preoperative Fibrinogen to Albumin Ratio in Patients with Glioblastoma: A Singe Center Experience

Overview

Journal Cancer Manag Res

Publisher Dove Medical Press

Specialty Oncology

Date 2021 Apr 22

PMID 33883939

Citations 7

Authors

Junhong Li

Xingwang Zhou

Yufan Xiang

Shuxin Zhang

Wentao Feng

Yunbo Yuan

Yanhui Liu

Senlin Yin

Affiliations

Soon will be listed here.

Abstract

Objective: To explore the prognostic value of preoperative fibrinogen to albumin ratio (FAR) in patients with glioblastoma (GBM) and its association with clinical characteristics.

Patients And Methods: A retrospective analysis was carried out on patients with newly diagnosed GBM who had undergone operation at the Department of Neurosurgery at West China Hospital between June 1st 2015 to June 31st 2018. Receiver operating characteristic (ROC) curves were performed to determine the optimal cut-off values for fibrinogen, albumin, neutrophil to lymphocyte ratio (NLR), and FAR by calculating the maximum Youden index. Kaplan-Meier curves and Cox regression analyses were applied to evaluate the prognostic value of FAR in GBM. Harrell concordance index (C-index) and Akaike information criterion (AIC) were calculated to compare different prognostic models.

Results: A total of 206 GBM patients were included in this research. The optimal cut-off value for fibrinogen, albumin, NLR, and FAR were 2.57, 42.4, 2.28, and 0.068 respectively. High FAR was significantly related to older age, KPS≤80, IDH-1 wildtype, presence of preoperative seizures, higher NLR, and tumor location. In Cox regression analyses, high FAR was significantly associated with poor prognosis. Prognostic models including FAR had the largest C-index and lowest AIC.

Conclusion: FAR was determined to be an independent risk factor of prognosis in patients with newly-diagnosed GBM. And the prognostic predictive ability of FAR is stronger than fibrinogen and albumin.

Citing Articles

Cytokine Profile in Development of Glioblastoma in Relation to Healthy Individuals.

Jarmuzek P, Defort P, Kot M, Wawrzyniak-Gramacka E, Morawin B, Zembron-Lacny A Int J Mol Sci. 2023; 24(22).

PMID: 38003396 PMC: 10671437. DOI: 10.3390/ijms242216206.

The fibrinogen-albumin ratio as a novel prognostic factor for elderly patients with osteosarcoma.

Fu Y, Yu Y, Zhou Y, Li T, Xie Y, Wang Y Medicine (Baltimore). 2023; 102(36):e34926.

PMID: 37682137 PMC: 10489207. DOI: 10.1097/MD.0000000000034926.

The association between fibrinogen-to-albumin ratio (FAR) and adverse prognosis in patients with acute decompensated heart failure at different glucose metabolic states.

Huang R, Dai Q, Chang L, Wang Z, Chen J, Gu R Cardiovasc Diabetol. 2022; 21(1):241.

PMID: 36371183 PMC: 9655790. DOI: 10.1186/s12933-022-01662-x.

The prognostic value of fibrinogen to albumin ratio in malignant tumor patients: A meta-analysis.

Li B, Deng H, Lei B, Chen L, Zhang X, Sha D Front Oncol. 2022; 12:985377.

PMID: 36249067 PMC: 9556778. DOI: 10.3389/fonc.2022.985377.

Prognostic Values of Combined Ratios of White Blood Cells in Glioblastoma: A Retrospective Study.

Jarmuzek P, Kot M, Defort P, Stawicki J, Komorzycka J, Nowak K J Clin Med. 2022; 11(12).

PMID: 35743468 PMC: 9225636. DOI: 10.3390/jcm11123397.

References

Liu M, Wang L . Prognostic significance of preoperative serum albumin, albumin-to-globulin ratio, and prognostic nutritional index for patients with glioma: A meta-analysis. Medicine (Baltimore). 2020; 99(27):e20927. PMC: 7337547. DOI: 10.1097/MD.0000000000020927. View

Polterauer S, Grimm C, Seebacher V, Concin N, Marth C, Tomovski C . Plasma fibrinogen levels and prognosis in patients with ovarian cancer: a multicenter study. Oncologist. 2009; 14(10):979-85. DOI: 10.1634/theoncologist.2009-0079. View

Wesseling P, Capper D . WHO 2016 Classification of gliomas. Neuropathol Appl Neurobiol. 2017; 44(2):139-150. DOI: 10.1111/nan.12432. View

Wang P, Zhang J, Cai H, Meng Z, Yu C, Li S . Sanbo Scoring System, Based on Age and Pre-treatment Hematological Markers, is a Non-invasive and Independent Prognostic Predictor for Patients with Primary Glioblastomas: A Retrospective Multicenter Study. J Cancer. 2019; 10(23):5654-5660. PMC: 6843864. DOI: 10.7150/jca.33047. View

Iqbal S . Role of thrombomodulin in cancer biology. Breast. 2004; 9(5):264-6. DOI: 10.1054/brst.2000.0186. View

Hao Y, Li X, Chen H, Huo H, Liu Z, Tian F . A Cumulative Score Based on Preoperative Neutrophil-Lymphocyte Ratio and Fibrinogen in Predicting Overall Survival of Patients with Glioblastoma Multiforme. World Neurosurg. 2019; 128:e427-e433. DOI: 10.1016/j.wneu.2019.04.169. View

Seebacher V, Grimm C, Reinthaller A, Heinze G, Tempfer C, Hefler L . The value of serum albumin as a novel independent marker for prognosis in patients with endometrial cancer. Eur J Obstet Gynecol Reprod Biol. 2013; 171(1):101-6. DOI: 10.1016/j.ejogrb.2013.07.044. View

He Z, Duan H, Lin F, Zhang J, Chen Y, Zhang G . Pretreatment neutrophil-to-lymphocyte ratio plus albumin-to-gamma-glutamyl transferase ratio predict the diagnosis of grade III glioma. Ann Transl Med. 2020; 7(22):623. PMC: 6944567. DOI: 10.21037/atm.2019.11.24. View

Vartanian A, Singh S, Agnihotri S, Jalali S, Burrell K, Aldape K . GBM's multifaceted landscape: highlighting regional and microenvironmental heterogeneity. Neuro Oncol. 2014; 16(9):1167-75. PMC: 4136895. DOI: 10.1093/neuonc/nou035. View

10.

Xie W, Leibl M, Clark M, Dohrmann P, Kunze T, Gieseler F . Activation of the coagulation system in cancerogenesis and metastasation. Biomed Pharmacother. 2005; 59(3):70-5. DOI: 10.1016/j.biopha.2005.01.001. View

11.

Luo Y, Kim H, Kim M, Lee M, Song Y . Elevated plasma fibrinogen levels and prognosis of epithelial ovarian cancer: a cohort study and meta-analysis. J Gynecol Oncol. 2017; 28(3):e36. PMC: 5391395. DOI: 10.3802/jgo.2017.28.e36. View

12.

Li S, Jiang Y, Lin J, Zhang J, Sun F, Gao Q . Albumin-to-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals. Cancer Med. 2018; 7(4):1221-1231. PMC: 5911606. DOI: 10.1002/cam4.1428. View

13.

Xu Q, Yan Y, Gu S, Mao K, Zhang J, Huang P . A Novel Inflammation-Based Prognostic Score: The Fibrinogen/Albumin Ratio Predicts Prognoses of Patients after Curative Resection for Hepatocellular Carcinoma. J Immunol Res. 2018; 2018:4925498. PMC: 6031154. DOI: 10.1155/2018/4925498. View

14.

Garcia-Martinez R, Caraceni P, Bernardi M, Gines P, Arroyo V, Jalan R . Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications. Hepatology. 2013; 58(5):1836-46. DOI: 10.1002/hep.26338. View

15.

Iyengar N, Gucalp A, Dannenberg A, Hudis C . Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation. J Clin Oncol. 2016; 34(35):4270-4276. PMC: 5562428. DOI: 10.1200/JCO.2016.67.4283. View

16.

Kao H, Lofstrand J, Loh C, Wei-Kai Lao W, Yi J, Chang Y . Nomogram based on albumin and neutrophil-to-lymphocyte ratio for predicting the prognosis of patients with oral cavity squamous cell carcinoma. Sci Rep. 2018; 8(1):13081. PMC: 6117301. DOI: 10.1038/s41598-018-31498-z. View

17.

Pearson J, Regad T . Targeting cellular pathways in glioblastoma multiforme. Signal Transduct Target Ther. 2017; 2:17040. PMC: 5661637. DOI: 10.1038/sigtrans.2017.40. View

18.

Lu J, Chen S, Li X, Qiu G, He S, Wang H . Gastrointestinal stromal tumors: Fibrinogen levels are associated with prognosis of patients as blood-based biomarker. Medicine (Baltimore). 2018; 97(17):e0568. PMC: 5944506. DOI: 10.1097/MD.0000000000010568. View

19.

Wu Y, Song Z, Sun K, Rong S, Gao P, Wang F . A Novel Scoring System Based on Peripheral Blood Test in Predicting Grade and Prognosis of Patients with Glioma. Onco Targets Ther. 2020; 12:11413-11423. PMC: 6935303. DOI: 10.2147/OTT.S236598. View

20.

Wang Y, Liu Z, Xu D, Liu M, Wang K, Xing B . Fibrinogen-Albumin Ratio Index (FARI): A More Promising Inflammation-Based Prognostic Marker for Patients Undergoing Hepatectomy for Colorectal Liver Metastases. Ann Surg Oncol. 2019; 26(11):3682-3692. DOI: 10.1245/s10434-019-07586-3. View